Manager, Theranostics Innovation

Company Description

UHN is Canada’s #1 hospital and the world’s #1 publicly funded hospital. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre. As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care.

UHN has the largest hospital-based research program in Canada, with major research in neurosciences, cardiology, transplantation, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. UHN is a research hospital affiliated with the University of Toronto.

UHN’s vision is to build A Healthier World and it’s only because of the talented and dedicated people who work here that we are continually bringing that vision closer to reality.

Union: Non Union
Number of vacancies: 1
Replacement or New: New
Site: Toronto General Hospital
Department: Research
Reports to: Director, Translational Research and Innovation
Hours: 37.5 hours per week
Wage Range: $103,155 - $153,155 per annum
Status: Permanent Full Time
Closing Date: October 1, 2026

The Manager, Theranostics Innovation will play a central role in building and scaling a next-generation theranostics program at University Health Network (UHN). This role sits at the intersection of clinical research, data and AI innovation, and strategic industry partnerships.

The successful candidate will help operationalize UHN’s Phase 0 clinical trials program, support the development of theranostics AI and data initiatives, and contribute to ecosystem-building activities with industry, academic, and healthcare partners. This is a unique opportunity to join a high-impact, fast-evolving program and help shape how theranostics is delivered, studied, and scaled within a leading global health system.

• Support the design, implementation, and ongoing operation of UHN’s Phase 0 theranostics clinical trials program, with a focus on program development, cross-functional alignment, and removing barriers to efficient trial delivery.
• Develop and implement standardized processes for study intake, feasibility, prioritization, onboarding, activation, and repeatable playbooks for early-phase studies.
• Coordinate across clinical trials units, principal investigators, imaging research operations, legal, regulatory, institutional review, and administrative stakeholders to support timely decision-making and issue resolution.
• Contribute to master services agreements, study-specific statements of work, scalable workflows, and approaches that support efficient activation, reduced patient burden, and alignment with institutional and regulatory requirements.
• Support the development and operationalization of UHN’s theranostics AI and data program by aligning data infrastructure, platforms, workflows, and AI use cases with clinical, research and operational needs.
• Facilitate coordination with AI research groups, information technology, software development teams, research support service cores, industry sponsors, commercialization teams, and legal stakeholders to enable pilot projects, implementation initiatives, and partnership opportunities.
• Support UHN’s theranostics ecosystem strategy by planning, coordinating, and executing forums, seminars, leadership events, workshops, working groups, strategic retreats, stakeholder meetings, agendas, materials, logistics, communications, summaries, notes, and follow-up actions.
• Lead day-to-day program management across multiple concurrent initiatives,…